Pharmaceutical

Vertex secures CHMP nod for Casgevy approval in Europe

Following US and UK approvals, the EMA’s CHMP has recommended conditional approval for Casgevy, with a decision expected in Q1 2024.

Dec 18, 2023 - 10:51
Vertex secures CHMP nod for Casgevy approval in Europe
Following US and UK approvals, the EMA’s CHMP has recommended conditional approval for Casgevy, with a decision expected in Q1 2024.
Read the original article

Tags:

Previous Article

Novo Nordisk Foundation sets up airborne infection vaccine initiative

Next Article

Biocytogen and Ona enter cancer ADC development deal

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: The biggest health care deals of 2023

STAT+: The biggest health care deals of 2023

Dec 17, 2023

STAT+: Wyden decries ‘astonishingly low’ tax rates for pharma companies as he probes business maneuvers

STAT+: Wyden decries ‘astonishingly low’ tax rates for ...

May 11, 2023

How a flexible FSP model fills the talent gap

How a flexible FSP model fills the talent gap

Aug 22, 2023